Results 111 to 120 of about 22,259 (250)

Hepatitis B in Organ Transplantation—Current Evidence and Clinical Gaps

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people.
Oscar A. Fernandez‐Garcia   +3 more
wiley   +1 more source

Epithelial membrane antigen expression in cholangiocarcinoma. An useful immunohistochemical tool for differential diagnosis with hepatocarcinoma

open access: yes, 1983
Twenty-two cases of primary hepatic tumours (16 hepatocarcinoma and 6 cholangiocarcinoma) have been studied by immunoperoxidase technique, for the presence of Epithelial Membrane Antigen (EMA).
M. Chilosi   +5 more
core   +1 more source

A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma

open access: yesJournal of Hepatocellular Carcinoma, 2015
François Cauchy, Jacques BelghitiHPB and Liver Transplantation Unit, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, FranceAbstract: Metabolic syndrome (MS), which is defined as a constellation of clinico-biological ...
Cauchy F, Belghiti J
doaj  

Hypoxia and the cytoskeleton

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Schematic outlining the activation of hypoxia‐sensitive pathways, the influence of hypoxia and associated pathways on the cytoskeleton, and the impact of these on disease progression. Abstract A highly‐regulated and dynamic cytoskeleton is vital for functional cellular physiology and the maintenance of homeostasis.
Darragh Flood, Cormac T. Taylor
wiley   +1 more source

Knockout of alpha6 beta1-integrin expression reverses the transformed phenotype of hepatocarcinoma cells

open access: yes, 1998
BACKGROUND and AIMS: Hepatocellular carcinoma is a common complication in liver cirrhosis. The integrin alpha6 beta1, a receptor for the laminin family of extracellular matrix proteins, has been found to be overexpressed in hepatocarcinoma.
Romanelli, Roberto G.   +13 more
core   +1 more source

Knockdown of mitotically associated long non‐coding RNA dysregulates endothelial functions, transcriptome and proteome

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Downregulation of mitotically associated long non‐coding RNA (MANCR) disturbs transcriptome and proteome in endothelial cells, possibly leading to endothelial and vascular dysfunction in preeclampsia. Abstract Preeclampsia (PE) is a hypertensive disorder during pregnancy, which is characterized by a wide spectrum of endothelial ...
Si‐Yan Zhang, Chi Zhou, Jing Zheng
wiley   +1 more source

Resecciones hepáticas en el servicio de Cirugía General del Hospital Privado: 13 años de experiencia resecciones hepáticas.

open access: yesRevista de la Facultad de Ciencias Médicas de Córdoba, 2019
Antecedentes: Las resecciones hepáticas constituyen el tratamiento de elección en las neoplasias hepáticas primarias yen algunos casos de tumores metastáticos, pero conllevan  tasas significativas de morbilidad y mortalidad.
Julia Samamé   +4 more
doaj  

Cholangiocellular hepatocarcinoma

open access: yesAnnals of Hepatology, 2008
Mario Alfonso Reséndiz-Morán   +2 more
openaire   +3 more sources

Pediculate hepatocarcinoma.

open access: yes, 1988
PAn excep\ional case o1 pedlcula\e hepa\ocarcinomaoccurring in a previous pathological liver (massivesteatosis) is presentad.
Davidenko, Nicolás   +3 more
openaire   +1 more source

The Nucleoside Analogue NITD008, Alone or Combined With Ribavirin, Potently Reduces Hepatitis E Virus Infection in Humanised Mice

open access: yesLiver International, Volume 46, Issue 12, December 2026.
ABSTRACT Background and Aims Hepatitis E virus (HEV) infection is becoming increasingly clinically relevant worldwide, but no approved antiviral therapy currently exists. Ribavirin (RBV) is used off‐label for immunosuppressed patients with chronic hepatitis E, although it is effective in only 80% of patients and linked to side effects.
Annika Volmari   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy